Exosomal miR-92b-5p regulates N4BP1 to enhance PTEN mono-ubiquitination in doxorubicin-resistant AML

Abstract

Aim: Doxorubicin, pivotal for acute myeloid leukemia (AML) treatment, often succumbs to resistance, impeding therapeutic success. Although exosomal transfer is linked to chemoresistance, the detailed role of exosomal miRNAs in doxorubicin resistance remains incompletely understood.

Methods: We employed miRNA sequencing to delineate the profile of exosomal miRNAs in doxorubicin-resistant K562/DOX cells and AML patients. Subsequently, qPCR was utilized to scrutinize the expression of exosomal miR-92b-5p in these resistant cells and AML patients. A dual-luciferase reporter assay was conducted to elucidate the direct binding of miR-92b-5p to NEDD4 binding protein 1 (N4BP1). Furthermore, interactions between N4BP1 and NEDD4, as well as between NEDD4 and PTEN, were investigated by co-immunoprecipitation (Co-IP). Meanwhile, the ubiquitination of PTEN was also examined by Co-IP. Western blot analysis was applied to assess the expression levels of N4BP1, NEDD4, PTEN, RAD51, and proteins associated with the PI3K-AKT-mTOR pathway. Gain- and loss-of-function studies were conducted to ascertain the functional role of miR-92b-5p in doxorubicin resistance by using miR-92b-5p-mimic and miR-92b-5p-inhibitor transfections.

Results: Our study found exosomal miR-92b-5p was upregulated both in doxorubicin-resistant cells and AML patients. Moreover, miR-92b-5p targets N4BP1, promoting NEDD4-mediated mono-ubiquitination of PTEN. This alters PTEN’s subcellular localization, promoting nuclear PTEN and reducing cytoplasmic PTEN, which in turn leads to increased RAD51 for DNA repair and activation of the PI3K-AKT-mTOR pathway for cell proliferation, contributing to doxorubicin resistance.

Conclusion: Our study reveals a novel mechanism of doxorubicin resistance mediated by exosomal miR-92b-5p and provides potential therapeutic targets for overcoming drug resistance in AML.

Keywords

Exosomal miR-92b-5p / N4BP1 / NEDD4 / PTEN / doxorubicin resistance / AML

References

[1] Hackl H,Wieser R.Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.J Hematol Oncol2017;10:51 PMCID:PMC5322789

[2] He B,Cai Q.miRNA-based biomarkers, therapies, and resistance in cancer.Int J Biol Sci2020;16:2628-47 PMCID:PMC7415433

[3] Giovannetti E,Smit J,Peters GJ.Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.Crit Rev Oncol Hematol2012;81:103-22

[4] Bhat AA,Raza SS.Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance.Mol Cancer2020;19:57 PMCID:PMC7069174

[5] Seca H,Almeida GM.Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia cells.Curr Pharm Biotechnol2014;15:492-502

[6] Yamamoto H,Oba S.miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target.Sci Rep2016;6:19204 PMCID:PMC4709720

[7] Liu H,Zhang J.Downregulated miR-130a enhances the sensitivity of acute myeloid leukemia cells to adriamycin.Mol Med Rep2020;22:2810-6 PMCID:PMC7453506

[8] Pathan M,Chitti SV.Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles.Nucleic Acids Res2019;47:D516-9 PMCID:PMC6323905

[9] Fontana F,Melling GE.Extracellular vesicles: emerging modulators of cancer drug resistance.Cancers2021;13:749 PMCID:PMC7916933

[10] Cariello M,Piacente M,Fasano A.Drug resistance: the role of exosomal miRNA in the microenvironment of hematopoietic tumors.Molecules2022;28:116 PMCID:PMC9821808

[11] Guo QR,Yan YD.The role of exosomal microRNA in cancer drug resistance.Front Oncol2020;10:472 PMCID:PMC7154138

[12] Wu J,Li X.Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.Biochem Biophys Res Commun2022;622:149-56

[13] Li H,Lu Y,Guan F.Exosomal miR92a promotes cytarabine resistance in myelodysplastic syndromes by activating Wnt/β-catenin signal pathway.Biomolecules2022;12:1448 PMCID:PMC9599242

[14] Jiang Y,Huang S.Extracellular vesicle-mediated regulation of imatinib resistance in chronic myeloid leukemia via the miR-629-5p/SENP2/PI3K/AKT/mTOR axis.Hematology2024;29:2379597

[15] Min QH,Zhang J.Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365.Exp Cell Res2018;362:386-93

[16] Bouvy C,Laloy J,Dogné JM.Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.Leuk Res2017;62:70-6

[17] Fishman A.QsRNA-seq: a protocol for generating libraries for high-throughput sequencing of small RNAs.Bio Protoc2019;9:e3179 PMCID:PMC7854107

[18] Robinson MD,Smyth GK.edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.Bioinformatics2010;26:139-40 PMCID:PMC2796818

[19] Betel D,Gabow A,Sander C.The microRNA.org resource: targets and expression.Nucleic Acids Res2008;36:D149-53 PMCID:PMC2238905

[20] Rehmsmeier M,Hochsmann M.Fast and effective prediction of microRNA/target duplexes.RNA2004;10:1507-17 PMCID:PMC1370637

[21] Deng YY,Wu SF.Integrated nr database in protein annotation system and its localization.Comput Eng2006;32:71-2

[22] Apweiler R,Wu CH.UniProt: the Universal Protein knowledgebase.Nucleic Acids Res2004;32:D115-9 PMCID:PMC308865

[23] Ashburner M,Blake JA.Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.Nat Genet2000;25:25-9 PMCID:PMC3037419

[24] Tatusov RL,Natale DA.The COG database: a tool for genome-scale analysis of protein functions and evolution.Nucleic Acids Res2000;28:33-6 PMCID:PMC102395

[25] Kanehisa M,Kawashima S,Hattori M.The KEGG resource for deciphering the genome.Nucleic Acids Res2004;32:D277-80 PMCID:PMC308797

[26] Koonin EV,Jackson JD.A comprehensive evolutionary classification of proteins encoded in complete eukaryotic genomes.Genome Biol2004;5:R7 PMCID:PMC395751

[27] Eddy SR.Profile hidden Markov models.Bioinformatics1998;14:755-63

[28] Mao X,Olyarchuk JG.Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary.Bioinformatics2005;21:3787-93

[29] Trotman LC,Alimonti A.Ubiquitination regulates PTEN nuclear import and tumor suppression.Cell2007;128:141-56 PMCID:PMC1855245

[30] Pei X,Soni A,Stuschke M.PTEN loss enhances error-prone DSB processing and tumor cell radiosensitivity by suppressing RAD51 expression and homologous recombination.Int J Mol Sci2022;23:12876 PMCID:PMC9658850

[31] Naci D,Barabé F.Cell adhesion to collagen promotes leukemia resistance to doxorubicin by reducing DNA damage through the inhibition of Rac1 activation.Sci Rep2019;9:19455 PMCID:PMC6923425

[32] Fadeev RS,Slyadovskiy DA.Cell aggregation increases drug resistance of acute myeloid leukemia cells.Biochem Moscow Suppl Ser A2015;9:135-43

[33] Wu T,Du Y,Zhou Z.Serum exosomal miR-92b-5p as a potential biomarker for acute heart failure caused by dilated cardiomyopathy.Cell Physiol Biochem2018;46:1939-50

[34] Yang Q,Shi Z.Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.J Exp Clin Cancer Res2021;40:120 PMCID:PMC8022546

[35] Zhu Z,Xiang Q.MiRNA-671-5p promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.Cell Death Dis2020;11:949 PMCID:PMC7642259

[36] Jin W,Liu M.Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells.Onco Targets Ther2019;12:6865-73 PMCID:PMC6709824

[37] Lin JC,Tsai JT.miR-671-5p Inhibition by MSI1 promotes glioblastoma tumorigenesis via radioresistance, tumor motility and cancer stem-like cell properties.Biomedicines2021;10:21 PMCID:PMC8773172

[38] Gungormez C,Dilsiz N.Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.Mol Biol Rep2019;46:4175-83

[39] Sun L,Zhao X,Wang Y.Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients.Front Genet2023;14:1102171 PMCID:PMC10083302

[40] Yang L,Liu C,Dong B.MiR-92 family members form a cluster required for notochord tubulogenesis in urochordate ciona savignyi.Genes2021;12:406 PMCID:PMC8001136

[41] Høgdall D,Larsen FO.Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.J Hepatol2022;77:1047-58

[42] Barquet-Muñoz SA,Perez-Plasencia C.microRNA profile associated with positive lymph node metastasis in early-stage cervical cancer.Curr Oncol2022;29:243-54 PMCID:PMC8774324

[43] Xu J,Li S.Immune-related nine-microRNA signature for predicting the prognosis of gastric cancer.Front Genet2021;12:690598 PMCID:PMC8287335

[44] Kan JY,Yang SF.Exosomal microRNA-92b is a diagnostic biomarker in breast cancer and targets survival-related MTSS1L to promote tumorigenesis.Int J Mol Sci2024;25:1295 PMCID:PMC10816035

[45] Kim DH,Choi YJ.Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer.Biomark Res2023;11:80 PMCID:PMC10500735

[46] Murillas R,Hatakeyama S,Kuehn MR.Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase.J Biol Chem2002;277:2897-907

[47] Sharma P,Zhang H.N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies.J Cell Sci2010;123:1227-34 PMCID:PMC2848111

[48] Chiyomaru T,Zaman MS.Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.PLoS One2012;7:e43812 PMCID:PMC3426544

[49] Xu J,Shi H,Yao S.miR-28-5p promotes the development and progression of ovarian cancer through inhibition of N4BP1.Int J Oncol2017;50:1383-91

[50] Hu H,Kang X,Zeng S.Extracellular vesicles derived from lung cancer cells promote the progression of lung cancer by delivering miR-151a-5p.Exp Cell Res2023;425:113526

[51] Oberst A,Aqeilan RI.The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch.Proc Natl Acad Sci U S A2007;104:11280-5 PMCID:PMC2040890

[52] Wang X,Wang J,Jiang X.Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation.Biochem J2008;414:221-9

[53] Wang ZW,Ye M,Chu M.NEDD4 E3 ligase: functions and mechanism in human cancer.Semin Cancer Biol2020;67:92-101

[54] Fouladkou F,Kawabe H.The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization.Proc Natl Acad Sci U S A2008;105:8585-90 PMCID:PMC2438405

[55] Wang X,Koppie T.NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.Cell2007;128:129-39 PMCID:PMC1828909

[56] Drinjakovic J,Campbell DS,Dwivedy A.E3 ligase Nedd4 promotes axon branching by downregulating PTEN.Neuron2010;65:341-57 PMCID:PMC2862300

[57] Dong L,Liu L.Smurf1 suppression enhances temozolomide chemosensitivity in glioblastoma by facilitating PTEN nuclear translocation.Cells2022;11:3302 PMCID:PMC9600526

[58] Bonilla B,Grundy MK.RAD51 gene family structure and function.Annu Rev Genet2020;54:25-46 PMCID:PMC7703940

[59] Xie C,Edwards H.Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.PLoS One2013;8:e79106 PMCID:PMC3823972

[60] Lai TH,Zecevic A.HDAC inhibition induces microRNA-182, which targets RAD51 and impairs HR repair to sensitize cells to sapacitabine in acute myelogenous leukemia.Clin Cancer Res2016;22:3537-49 PMCID:PMC4947457

[61] Huang ZJ,Yang XY.NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma.Oncol Lett2017;14:2649-56 PMCID:PMC5588169

[62] Wen W,Wang L.Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells.Cell Cycle2017;16:1509-14 PMCID:PMC5584855

[63] Chen CY,He L.PTEN: tumor suppressor and metabolic regulator.Front Endocrinol2018;9:338 PMCID:PMC6046409